DJ Sullivan, M Franchini, MJ Joyner… - Nature …, 2022 - ncbi.nlm.nih.gov
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
DJ Sullivan, M Franchini, MJ Joyner… - Nature …, 2022 - europepmc.org
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
DJ Sullivan, M Franchini, MJ Joyner… - Nature …, 2022 - search.ebscohost.com
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
DJ Sullivan, M Franchini, MJ Joyner… - Nature …, 2022 - ideas.repec.org
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
DJ Sullivan, M Franchini, MJ Joyner… - Nature …, 2022 - econpapers.repec.org
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
DJ Sullivan, M Franchini, MJ Joyner… - Nature …, 2022 - pure.johnshopkins.edu
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
DJ Sullivan, M Franchini, MJ Joyner… - Nature …, 2022 - ui.adsabs.harvard.edu
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
DJ Sullivan, M Franchini, MJ Joyner, A Casadevall… - 2022 - cabidigitallibrary.org
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …
DJ Sullivan, M Franchini, MJ Joyner… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …